NO812529L - Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo-diazepin-derivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo-diazepin-derivaterInfo
- Publication number
- NO812529L NO812529L NO812529A NO812529A NO812529L NO 812529 L NO812529 L NO 812529L NO 812529 A NO812529 A NO 812529A NO 812529 A NO812529 A NO 812529A NO 812529 L NO812529 L NO 812529L
- Authority
- NO
- Norway
- Prior art keywords
- dibenzo
- dihydro
- diazepin
- general formula
- methyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 10
- 238000002360 preparation method Methods 0.000 title claims description 7
- 230000001225 therapeutic effect Effects 0.000 title description 2
- 150000008533 dibenzodiazepines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 50
- -1 pyrrolidino, piperidino, 2-methyl-piperidino, 2-ethyl-piperidino, 2,6-dimethyl-piperidino Chemical group 0.000 claims abstract description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 10
- 239000001257 hydrogen Substances 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- 229910052801 chlorine Chemical group 0.000 claims abstract description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 3
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims abstract description 3
- 150000001412 amines Chemical class 0.000 claims description 10
- 239000007858 starting material Substances 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 150000007522 mineralic acids Chemical class 0.000 claims description 5
- 150000007524 organic acids Chemical class 0.000 claims description 5
- 235000005985 organic acids Nutrition 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 2
- JGZLXFZEFXOFNM-UHFFFAOYSA-N 11-(3-piperidin-1-ylpropanoyl)-5h-benzo[b][1,4]benzodiazepin-6-one Chemical compound C12=CC=CC=C2NC(=O)C2=CC=CC=C2N1C(=O)CCN1CCCCC1 JGZLXFZEFXOFNM-UHFFFAOYSA-N 0.000 claims 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 239000000460 chlorine Chemical group 0.000 abstract description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract description 3
- 239000002253 acid Substances 0.000 abstract description 3
- 230000000026 anti-ulcerogenic effect Effects 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000002731 stomach secretion inhibitor Substances 0.000 abstract 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 46
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 34
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 23
- 238000010992 reflux Methods 0.000 description 21
- 239000011541 reaction mixture Substances 0.000 description 20
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 239000002904 solvent Substances 0.000 description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000012433 hydrogen halide Substances 0.000 description 9
- 229910000039 hydrogen halide Inorganic materials 0.000 description 9
- QPHUWSLVGFCPLN-UHFFFAOYSA-N 11-(3-chloropropanoyl)-5-methylbenzo[b][1,4]benzodiazepin-6-one Chemical compound O=C1N(C)C2=CC=CC=C2N(C(=O)CCCl)C2=CC=CC=C21 QPHUWSLVGFCPLN-UHFFFAOYSA-N 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 7
- 238000001953 recrystallisation Methods 0.000 description 7
- LEGYNZZRECSDDJ-UHFFFAOYSA-N 11-(3-chloropropanoyl)-5h-benzo[b][1,4]benzodiazepin-6-one Chemical compound N1C(=O)C2=CC=CC=C2N(C(=O)CCCl)C2=CC=CC=C21 LEGYNZZRECSDDJ-UHFFFAOYSA-N 0.000 description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000003513 alkali Substances 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- NNWUEBIEOFQMSS-UHFFFAOYSA-N 2-Methylpiperidine Chemical compound CC1CCCCN1 NNWUEBIEOFQMSS-UHFFFAOYSA-N 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- HDZZIBOAYMLNFO-UHFFFAOYSA-N 8-chloro-11-(3-chloropropanoyl)-5h-benzo[b][1,4]benzodiazepin-6-one Chemical compound N1C(=O)C2=CC(Cl)=CC=C2N(C(=O)CCCl)C2=CC=CC=C21 HDZZIBOAYMLNFO-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- LJYVIIWSTMUPQD-UHFFFAOYSA-N 8-chloro-11-(3-chloropropanoyl)-5-methylbenzo[b][1,4]benzodiazepin-6-one Chemical compound O=C1N(C)C2=CC=CC=C2N(C(=O)CCCl)C2=CC=C(Cl)C=C21 LJYVIIWSTMUPQD-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- REORPVRHNNILDQ-UHFFFAOYSA-N 11-(3-chloropropanoyl)-5-ethylbenzo[b][1,4]benzodiazepin-6-one Chemical compound O=C1N(CC)C2=CC=CC=C2N(C(=O)CCCl)C2=CC=CC=C21 REORPVRHNNILDQ-UHFFFAOYSA-N 0.000 description 2
- QBBKKFZGCDJDQK-UHFFFAOYSA-N 2-ethylpiperidine Chemical compound CCC1CCCCN1 QBBKKFZGCDJDQK-UHFFFAOYSA-N 0.000 description 2
- XRMZIWPMIIREDH-UHFFFAOYSA-N 3-chloro-11-(3-chloropropanoyl)-5h-benzo[b][1,4]benzodiazepin-6-one Chemical compound N1C(=O)C2=CC=CC=C2N(C(=O)CCCl)C2=CC=C(Cl)C=C21 XRMZIWPMIIREDH-UHFFFAOYSA-N 0.000 description 2
- KVVFXAAMMFTLGN-UHFFFAOYSA-N 5,11-dihydrobenzo[b][1,4]benzodiazepin-6-one Chemical compound O=C1NC2=CC=CC=C2NC2=CC=CC=C12 KVVFXAAMMFTLGN-UHFFFAOYSA-N 0.000 description 2
- PVJBJAPICXOLPS-UHFFFAOYSA-N 5-methyl-11-(3-pyrrolidin-1-ylpropanoyl)benzo[b][1,4]benzodiazepin-6-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C(=O)N(C)C2=CC=CC=C2N1C(=O)CCN1CCCC1 PVJBJAPICXOLPS-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 230000002911 mydriatic effect Effects 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- BNJSMSKXZORWQE-UHFFFAOYSA-N 11-(3-piperidin-1-ylpropanoyl)-5h-benzo[b][1,4]benzodiazepin-6-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2NC(=O)C2=CC=CC=C2N1C(=O)CCN1CCCCC1 BNJSMSKXZORWQE-UHFFFAOYSA-N 0.000 description 1
- KENKOHVEGCUREW-UHFFFAOYSA-N 11-(3-pyrrolidin-1-ylpropanoyl)-5h-benzo[b][1,4]benzodiazepin-6-one Chemical compound C12=CC=CC=C2NC(=O)C2=CC=CC=C2N1C(=O)CCN1CCCC1 KENKOHVEGCUREW-UHFFFAOYSA-N 0.000 description 1
- SSLNTZWPNHCUAM-UHFFFAOYSA-N 11-[3-(2,6-dimethylpiperidin-1-yl)propanoyl]-5-methylbenzo[b][1,4]benzodiazepin-6-one Chemical compound CC1CCCC(C)N1CCC(=O)N1C2=CC=CC=C2C(=O)N(C)C2=CC=CC=C21 SSLNTZWPNHCUAM-UHFFFAOYSA-N 0.000 description 1
- BTKLCYLKBLLYAQ-UHFFFAOYSA-N 11-prop-2-enoyl-5h-benzo[b][1,4]benzodiazepin-6-one Chemical compound N1C(=O)C2=CC=CC=C2N(C(=O)C=C)C2=CC=CC=C21 BTKLCYLKBLLYAQ-UHFFFAOYSA-N 0.000 description 1
- SDGKUVSVPIIUCF-UHFFFAOYSA-N 2,6-dimethylpiperidine Chemical compound CC1CCCC(C)N1 SDGKUVSVPIIUCF-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- KCIYKFOWPKGTFH-UHFFFAOYSA-N 3-chloro-11-[3-(2-methylpiperidin-1-yl)propanoyl]-5h-benzo[b][1,4]benzodiazepin-6-one Chemical compound CC1CCCCN1CCC(=O)N1C2=CC=CC=C2C(=O)NC2=CC(Cl)=CC=C21 KCIYKFOWPKGTFH-UHFFFAOYSA-N 0.000 description 1
- INUNLMUAPJVRME-UHFFFAOYSA-N 3-chloropropanoyl chloride Chemical compound ClCCC(Cl)=O INUNLMUAPJVRME-UHFFFAOYSA-N 0.000 description 1
- ROLMZTIHUMKEAI-UHFFFAOYSA-N 4,5-difluoro-2-hydroxybenzonitrile Chemical compound OC1=CC(F)=C(F)C=C1C#N ROLMZTIHUMKEAI-UHFFFAOYSA-N 0.000 description 1
- BPFHUEVZFHBKQO-UHFFFAOYSA-N 5-ethyl-11-[3-(2-methylpiperidin-1-yl)propanoyl]benzo[b][1,4]benzodiazepin-6-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2C(=O)N(CC)C2=CC=CC=C2N1C(=O)CCN1CCCCC1C BPFHUEVZFHBKQO-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- CAEMOCYUHNETJU-UHFFFAOYSA-N 8-chloro-11-(3-piperidin-1-ylpropanoyl)-5h-benzo[b][1,4]benzodiazepin-6-one Chemical compound C12=CC=CC=C2NC(=O)C2=CC(Cl)=CC=C2N1C(=O)CCN1CCCCC1 CAEMOCYUHNETJU-UHFFFAOYSA-N 0.000 description 1
- SZUAAASCCWAYEX-UHFFFAOYSA-N 8-chloro-5-methyl-11-(3-pyrrolidin-1-ylpropanoyl)benzo[b][1,4]benzodiazepin-6-one Chemical compound C12=CC=C(Cl)C=C2C(=O)N(C)C2=CC=CC=C2N1C(=O)CCN1CCCC1 SZUAAASCCWAYEX-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000160765 Erebia ligea Species 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000006550 Mydriasis Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000001262 anti-secretory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-M fumarate(1-) Chemical compound OC(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-M 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Photoreceptors In Electrophotography (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19803028001 DE3028001A1 (de) | 1980-07-24 | 1980-07-24 | Neue, in 5-stellung substituierte 5,10-dihydro-11h-dibenzo (b,e)(1,4) diazepin-11-one, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO812529L true NO812529L (no) | 1982-01-25 |
Family
ID=6107969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO812529A NO812529L (no) | 1980-07-24 | 1981-07-23 | Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo-diazepin-derivater |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4377576A (sv) |
| EP (1) | EP0044989B1 (sv) |
| JP (1) | JPS5756470A (sv) |
| AT (1) | ATE3548T1 (sv) |
| AU (1) | AU543677B2 (sv) |
| CA (1) | CA1154763A (sv) |
| DD (1) | DD202023A5 (sv) |
| DE (2) | DE3028001A1 (sv) |
| DK (1) | DK326481A (sv) |
| ES (1) | ES8301224A1 (sv) |
| FI (1) | FI67697C (sv) |
| GB (1) | GB2081264B (sv) |
| GR (1) | GR75281B (sv) |
| HU (1) | HU187340B (sv) |
| IL (1) | IL63381A0 (sv) |
| NO (1) | NO812529L (sv) |
| NZ (1) | NZ197809A (sv) |
| PH (1) | PH16815A (sv) |
| PT (1) | PT73402B (sv) |
| YU (1) | YU182581A (sv) |
| ZA (1) | ZA815043B (sv) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3204158A1 (de) * | 1982-02-06 | 1983-08-11 | Dr. Karl Thomae Gmbh, 7950 Biberach | "substituierte dibenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel" |
| DE3204157A1 (de) * | 1982-02-06 | 1983-08-11 | Dr. Karl Thomae Gmbh, 7950 Biberach | Substituierte dibenzodiazepinone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
| DE3204403A1 (de) | 1982-02-09 | 1983-08-11 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue pyridobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| IT1212743B (it) * | 1983-05-17 | 1989-11-30 | Dompe Farmaceutici Spa | Sali quaternari di derivati di benzo[ 1,4 ]diazepinonici,pirido [1,4]benzodiazepinonici,prido [1,5]benzodiazepinonici e loro atti vita' farmacologica |
| IT1212742B (it) * | 1983-05-17 | 1989-11-30 | Dompe Farmaceutici Spa | Derivati dibenzo [1,4]diazepinonici pirido [1,4] benzodiazepinonici,pirido [1,5] benzodiazepinonici e loro attivita' farmacologica |
| DD236731B3 (de) * | 1983-10-19 | 1992-12-10 | Dresden Arzneimittel | Verfahren zur herstellung von neuen in 5-stellung substituierten 5,10-dihydro-11h-dibenzo|b,e¨|1,4¨diazepin-11-onen |
| DE3409237A1 (de) * | 1984-03-14 | 1985-09-19 | Dr. Karl Thomae Gmbh, 7950 Biberach | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3531682A1 (de) * | 1985-09-05 | 1987-03-12 | Thomae Gmbh Dr K | (+)-6-chlor-5,10-dihydro-5-((1-methyl-4- piperidinyl)acetyl)-11h-dibenzo(b,e)(1,4) diazepin-11-on, seine isolierung und verwendung als arzneimittel |
| DE3643666A1 (de) * | 1986-12-20 | 1988-06-30 | Thomae Gmbh Dr K | Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DD293582A5 (de) * | 1989-07-31 | 1991-09-05 | Arzneimittelwerk Dresden,De | Neue 5-(omega-aminoacyl)-5,10-dihydro-11h-dibenzo/b,e//1,4/-diazepin-11-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US6277592B1 (en) | 1996-07-31 | 2001-08-21 | Purina Mills, Inc. | Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| US6297027B1 (en) | 1996-07-31 | 2001-10-02 | Purina Mills, Inc. | Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| WO2007056388A2 (en) * | 2005-11-07 | 2007-05-18 | The General Hospital Corporation | Compositions and methods for modulating poly (adp-ribose) polymerase activity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1795176C3 (de) * | 1968-08-20 | 1974-10-24 | Dr. Karl Thomae Gmbh, 7950 Biberach | hT-substituierte 5-Aminoacetyl-5,10-dihydro-l lH-dibenzo eckige Klammer auf b,e eckige Klammer zu eckige Klammer auf 1,4 eckige Klammer zu diazepin-11one und Verfahren zu ihrer Herstellung |
| DE1931487C3 (de) * | 1969-06-20 | 1975-12-18 | Dr. Karl Thomae Gmbh, 7950 Biberach | In 5-Stellung substituierte 5,10-Dihydro-11H-dibenzo eckige Klammer auf b,e eckige Klammer zu eckige Klammer auf 1,4 eckige Klammer zu diazepin-11 -one und Verfahren zu ihrer Herstellung |
| FI49509C (sv) * | 1968-08-20 | 1975-07-10 | Thomae Gmbh Dr K | Förfarande för framställning av farmakologiskt aktiva i 5-ställning as ubstituerade 5,10-dihydro-11H-dibenzo/b,e//1,4/diazepin-11-oner och de ras salter. |
-
1980
- 1980-07-24 DE DE19803028001 patent/DE3028001A1/de not_active Withdrawn
-
1981
- 1981-07-11 EP EP81105421A patent/EP0044989B1/de not_active Expired
- 1981-07-11 AT AT81105421T patent/ATE3548T1/de not_active IP Right Cessation
- 1981-07-11 DE DE8181105421T patent/DE3160360D1/de not_active Expired
- 1981-07-13 US US06/282,501 patent/US4377576A/en not_active Expired - Fee Related
- 1981-07-17 DD DD81231897A patent/DD202023A5/de unknown
- 1981-07-20 GR GR65563A patent/GR75281B/el unknown
- 1981-07-20 JP JP56113421A patent/JPS5756470A/ja active Pending
- 1981-07-20 PT PT73402A patent/PT73402B/pt unknown
- 1981-07-22 YU YU01825/81A patent/YU182581A/xx unknown
- 1981-07-22 IL IL63381A patent/IL63381A0/xx unknown
- 1981-07-22 DK DK326481A patent/DK326481A/da not_active Application Discontinuation
- 1981-07-23 FI FI812321A patent/FI67697C/fi not_active IP Right Cessation
- 1981-07-23 GB GB8122782A patent/GB2081264B/en not_active Expired
- 1981-07-23 PH PH25957A patent/PH16815A/en unknown
- 1981-07-23 ES ES504206A patent/ES8301224A1/es not_active Expired
- 1981-07-23 NO NO812529A patent/NO812529L/no unknown
- 1981-07-23 AU AU73370/81A patent/AU543677B2/en not_active Expired - Fee Related
- 1981-07-23 ZA ZA815043A patent/ZA815043B/xx unknown
- 1981-07-23 HU HU812160A patent/HU187340B/hu unknown
- 1981-07-23 CA CA000382372A patent/CA1154763A/en not_active Expired
- 1981-07-23 NZ NZ197809A patent/NZ197809A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH16815A (en) | 1984-03-06 |
| GR75281B (sv) | 1984-07-13 |
| EP0044989B1 (de) | 1983-05-25 |
| DD202023A5 (de) | 1983-08-24 |
| EP0044989A1 (de) | 1982-02-03 |
| US4377576A (en) | 1983-03-22 |
| PT73402B (de) | 1983-06-15 |
| ES504206A0 (es) | 1982-11-16 |
| ES8301224A1 (es) | 1982-11-16 |
| NZ197809A (en) | 1983-06-14 |
| FI67697C (fi) | 1985-05-10 |
| GB2081264B (en) | 1984-01-25 |
| AU543677B2 (en) | 1985-04-26 |
| JPS5756470A (en) | 1982-04-05 |
| IL63381A0 (en) | 1981-10-30 |
| CA1154763A (en) | 1983-10-04 |
| FI67697B (fi) | 1985-01-31 |
| DE3160360D1 (en) | 1983-07-07 |
| PT73402A (de) | 1981-08-01 |
| YU182581A (en) | 1984-02-29 |
| DK326481A (da) | 1982-01-25 |
| FI812321L (fi) | 1982-01-25 |
| ZA815043B (en) | 1983-03-30 |
| GB2081264A (en) | 1982-02-17 |
| DE3028001A1 (de) | 1982-02-18 |
| AU7337081A (en) | 1982-01-28 |
| ATE3548T1 (de) | 1983-06-15 |
| HU187340B (en) | 1985-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO124073B (sv) | ||
| NO812529L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo-diazepin-derivater | |
| US3192204A (en) | Trifluoromethylthiaxanthene and -xanthene derivatives | |
| GB1581500A (en) | Pyridobenzodiazepines | |
| DK159441B (da) | 11-substituerede 5,11-dihydro-6h-dibenz(b,e)azepin-6-on-derivater, laegemidler indeholdende disse forbindelser og analogifremgangsmaade til forbindelsernes fremstilling | |
| NO149037B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
| NO149313B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
| NO158623B (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive dibenzodiazepinon derivater. | |
| NO144296B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(omega-(benzoylpiperidinyl)-alkyl)-fenothiaziner | |
| US4424226A (en) | Pyridobenzodiazepinones, pharmaceutical compositions thereof and method of use thereof | |
| JPS5959685A (ja) | 新規なピペリジン誘導体 | |
| US4442102A (en) | 1,5-Diphenylpyrazolin-3-one compounds, process and intermediates for preparation thereof and pharmaceutical compositions containing same | |
| US4424225A (en) | Thienobenzodiazepinones, pharmaceutical compositions thereof and method of use thereof | |
| PL69663B1 (sv) | ||
| US3474099A (en) | 4-piperazinyl thienobenzothiazepines | |
| NO753672L (sv) | ||
| NO124256B (sv) | ||
| US3720676A (en) | [4-(10,11-DIHYDRO-5H-DIBENZO[a,d]CYCLOHEPTEN-10-yL-1-PIPERAZINYL]-ALKYL]-3-ALKYL-2-IMIDAZOLIDINONES AS CNS DEPRESSANTS | |
| NO139125B (no) | Analogifremgangsmaate for fremstilling av cykloheksantetrolderivater | |
| DK153843B (da) | Analogifremgangsmaade til fremstilling af 5-substituerede 10,11-dihydro-5h-dibenzooea,daacyclohepten-5,10-iminer eller salte deraf | |
| US4311700A (en) | Pyrimidobenzodiazepinones, their use and medicaments containing them | |
| KR840000890B1 (ko) | 5-치환된 5, 10-디하이드로-11H-디벤조[b, e][1, 4]디아제핀-11-온의 제조방법 | |
| IL26534A (en) | Fused diazaheterocyclic ketone derivatives and their preparation | |
| US3720677A (en) | 4-(thieno[2,3-b][1,5]benzothiazepin-4-yl)-piperazinyl-alkyl-3-alkyl-2-imidazolidinones as cns-depressants | |
| CA1074798A (en) | Vinyl derivatives and process for preparing them |